Alert Banner Warning

COVID-19 Vaccine

Alert Banner X

Kids ages 6 months and older are now eligible for COVID-19 vaccine. In June 2022, the FDA and CDC granted emergency use authorization for Pfizer-BioNTech and Moderna vaccines in children ages 6 months to 5 years.

AHN Hypertrophic Cardiomyopathy (HCM) Program

Hypertrophic cardiomyopathy (HCM) is a serious condition that sometimes makes it harder for the heart to pump blood efficiently to the rest of the body. Experienced specialists at the AHN Hypertrophic Cardiomyopathy Clinic offer care for hypertrophic cardiomyopathy that can help ease patients’ symptoms and help them lead the lives they want. 

An overview of HCM

Hypertrophic cardiomyopathy causes the walls of the heart to abnormally thicken over time, making it difficult for the heart to do its job. High blood pressure or aging are sometimes to blame, but HCM is inherited in most cases.

HCM can be diagnosed at any age, though symptoms usually develop by middle age. Some people with HCM may not notice any indications, while others can experience symptoms like shortness of breath, chest pain, dizziness, fatigue, and more.

"We're fortunate because we have a team of experts who are dedicated on hypertrophic cardiomyopathy only. And it's not just in surgery. You need a heart failure cardiologist, a general cardiologist, an electrophysiologist, and a geneticist to contribute to great care for this population."

Pietro Bajona, MD, PhD - Director of Hypertrophic Cardiomyopathy Program

Obstructive and nonobstructive HCM

Most people with HCM have hypertrophic obstructive cardiomyopathy. This happens when the wall between the two bottom chambers of the heart thickens, and the walls of the pumping chambers become stiff. As a result, blood flow has a tougher time exiting the heart.

With nonobstructive HCM, blood leaves the heart normally, but the heart’s main pumping chamber is very stiff.

Learn more about hypertrophic cardiomyopathy symptoms, causes, and treatment.

About the Hypertrophic Cardiomyopathy Program

Experts at the AHN Cardiovascular Institute are highly experienced at diagnosing and treating all types of cardiomyopathy, including HCM . Our specialists can conduct noninvasive scans to determine the presence and extent of the condition. And, based on each patient’s unique needs, use medication for hypertrophic cardiomyopathy treatment or — in some cases — surgical interventions to provide relief.

Learn more about types of cardiomyopathy and treatment.

Program leaders

Pietro Bajona, MD

Pietro Bajona, MD

Director of Hypertrophic Cardiomyopathy

Craig Alpert, MD, FAAC

Craig Alpert, MD, FAAC

Medical Director, Hypertrophic Cardiomyopathy Program Director

Srinivas Murali, MD

Srinivas Murali, MD

System Chair, Department of Cardiovascular Medicine

Jennifer H Keeley, DNP

Jennifer H. Keeley, DNP, ANP-BC

Division of Heart Failure and Pulmonary Hypertension

Kathleen Ridgeway, RN

Kathleen Ridgeway, RN

Program Clinical Coordinator 

Team members

David Lasorda, DO, FACC
Interventional Cardiology

Mithun Chakravarthy, MD
Interventional Cardiology

Robert Biederman, MD, FACC, FAHA, FSGC, FASA
Cardiovascular Imaging

Victor Farah, MD, FACC
Cardiovascular Imaging

Rachel Hughes-Doichev, MD, FASE
Cardiovascular Imaging

George Shaw, MD, FACC, FHRS
Electrophysiology

Support staff

Rachel Evans, MSW, LSW
Supportive Care

Nonnie Toth, MS, RD, LDN
Nutrition

Contact us

Call (412) 359-4869 to speak with an HCM coordinator and make an appointment.

Find us

Allegheny General Hospital
320 East North Avenue
South Tower, First Floor
Pittsburgh, PA 15212
GET DIRECTIONS

Hours: 8:00 AM – 5:00 PM

Parking Information